Table of Contents
<< Previous Issue | Jun 2023 (Vol: 2023, Issue: 6) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Novartis Buys Avrobio’s Rare Disease Gene Therapy for US$87.5 M
-
Pyxis Oncology to Acquire Apexigen for US$16 M
-
Novartis to acquire Chinook Therapeutics for US$3.2 B to Bolster Kidney Disease Portfolio
-
Coherus Biosciences to Buy Surface Oncology for US$65 M
- Section: Research & Development
-
Novo Nordisk and Life Edit Therapeutics Enter Gene Editing Collaboration in Rare and Cardiometabolic Diseases
-
XtalPi Enters into Collaboration with Eli Lilly to Discover Drug Candidates Using Artificial Intelligence and Robotics Platform